Comparing the tuberculin skin test and T-SPOT.TB blood test in children

Pediatrics

Volumn 127, Issue 1, 2011, Pages

  Cruz, Andrea T ^a   Geltemeyer, Abby M ^b   Starke, Jeffrey R ^a   Flores, Jaime A ^b   Graviss, Edward A ^c   Smith, Kim C ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Children; Interferon release assay; T SPOT.TB; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CHILD; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; IMMUNE FUNCTION TEST; INFANT; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ALGORITHMS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC TESTS; HUMANS; INFANT; INTERFERON-GAMMA; MALE; PROSPECTIVE STUDIES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 78650780898     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-1725     Document Type: Article

References (35)

1. World Health Organization. Global tuberculosis control: 2009 report. Available at: http://whqlibdoc.who.int/publications/ 2009/9789241598866-eng.pdf. Accessed March 16, 2010
2. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence: recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD), and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002;19(4):765-775
3. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med. 2006; 173(10):1078-1090 (Pubitemid 43726888)
4. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country: WHO Global Surveillance and Monitoring Project. JAMA. 1999;282(7):677-686
5. Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000. Am J Respir Crit Care Med. 2008;177(3):348-355
6. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis. 1993; 17(6):968-975
7. Haimi-Cohen Y, Zeharia A, Mimouni M, Soukhman M, Amir J. Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin Infect Dis. 2001;33(10): 1786-1788 (Pubitemid 33044550)
8. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002;57(9):804-809
9. Pouchot J, Grasland A, Collet C, Coste J, Esdaile JM, Vinceneux P. Reliability of tuberculin skin test measurement. Ann Intern Med. 1997;126(3):210-214
10. Menzies D. Interpretation of repeated tuberculin tests: boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999; 159(1):15-21
11. Lewinsohn DA. Embracing interferon-gamma release assays for diagnosis of latent tuberculosis infection. Pediatr Infect Dis J. 2009;28(8):674-675
12. Haustein T, Ridout DA, Hartley JC, et al. The likelihood of an indeterminate test result from a whole-blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J. 2009;28(8):669-673
13. Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole-blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax. 2006;61(7):616-620 (Pubitemid 44035143)
14. Bergamini BM, Losi M, Valenti F, et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics. 2009; 123(3). Available at: http://www.pediatrics. org/cgi/content/full/123/3/e419
15. Bianchi L, Galli L, Moriondo M, et al. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J. 2009;28(6):510-514
16. Connell TG, Ritz N, Paxon GA, et al. A threeway comparison of tuberculin skin testing, QuantiFERON-TB Gold, and T-SPOT.TB in children. PLoS One. 2008;3(7):e2624
17. Detjen AK, Keil T, Roll S, et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis. 2007;45(3):322-328
18. Connell T, Bar-Zeev N, Curtis N. Early detection of perinatal tuberculosis using a whole-blood interferon-γ release assay. Clin Infect Dis. 2006;42(11):e82-e85
19. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-γ release assay for detection of active tuberculosis. Clin Infect Dis. 2007;44(1):69-73
20. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49(RR-6):1-51
21. Oxford Immunotec. T-SPOT.TB [package insert]. Available at: http://www.oxfordimmunotec.com/ eu/downloads/PI-TB96-IVD-UK-V8,%20English. pdf. Accessed May 18, 2010
22. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet. 2004;364(9452):2196-2203 (Pubitemid 40018449)
23. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent-tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177-184
24. Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis. Ann Intern Med. 2008;149(11):777-787
25. Lighter J, Rigaud M, Eduardo R, Peng C-H, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube Test. Pediatrics. 2009;123(1):30-37
26. Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-gamma release assays and tuberculin skin test for tracing TB contacts. Am J Respir Crit Care Med. 2007;175(6):618-627
27. Mazurek M, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee, Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection: United States, 2010. MMWR Recomm Rep. 2010;59(RR-5):1-25
28. Lewinsohn DA, Lobato MN, Jereb JA. Interferon-γ release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. Curr Opin Pediatr. 2010;22(1):71-76
29. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10(11):1192-1204
30. Sleiman R, Al-Tannir M, Dakdouki G, Ziade F, Assi NA, Rajab M. Interpretation of the tuberculin skin test in bacille Calmette-Guérin vaccinated and nonvaccinated schoolchildren. Pediatr Infect Dis J. 2007;26(2): 134-138
31. Khan K, Wang J, Marras TK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med. 2007;176(3): 306-313
32. Khan K, Wang J, Hu W, Bierman A, Li Y, Gardam M. Tuberculosis infection in the United States: national trends over three decades. Am J Respir Crit Care Med. 2008;177(4): 455-460 (Pubitemid 351317590)
33. Connell TG, Tebruegge M, Ritz N, et al. Indeterminate interferon-gamma release assay results in children. Pediatr Infect Dis J. 2010;29(3):285-286
34. Young TK, Mirdad S. Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination. Tuber Lung Dis. 1992;73(2):94-100
35. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-gamma assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One. 2009;4(12): e8517